BR112022026865A2 - Pastilha - Google Patents

Pastilha

Info

Publication number
BR112022026865A2
BR112022026865A2 BR112022026865A BR112022026865A BR112022026865A2 BR 112022026865 A2 BR112022026865 A2 BR 112022026865A2 BR 112022026865 A BR112022026865 A BR 112022026865A BR 112022026865 A BR112022026865 A BR 112022026865A BR 112022026865 A2 BR112022026865 A2 BR 112022026865A2
Authority
BR
Brazil
Prior art keywords
weight
tablet
lozenge
sweetener
pectin
Prior art date
Application number
BR112022026865A
Other languages
English (en)
Inventor
Earl England Kenneth
Akash Patel Shivangi
Hue Yang Chue
Original Assignee
Glaxosmithkline Consumer Healthcare Holdings Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Consumer Healthcare Holdings Us Llc filed Critical Glaxosmithkline Consumer Healthcare Holdings Us Llc
Publication of BR112022026865A2 publication Critical patent/BR112022026865A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PASTILHA. A presente invenção refere-se a uma pastilha que compreende de 1,4 a 18% em peso de pectina; de 78 a 88% em peso de adoçante; de 0,1 a 15% de um ácido orgânico; e 10 a 19% em peso de água. Um método de tratamento de dores de garganta compreende a aplicação da pastilha da reivindicação 1 a uma cavidade oral de um paciente em necessidade; e a dissolução da pastilha durante um período de pelo menos 5 minutos.
BR112022026865A 2020-06-30 2021-06-28 Pastilha BR112022026865A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063045947P 2020-06-30 2020-06-30
PCT/US2021/039310 WO2022005932A1 (en) 2020-06-30 2021-06-28 Lozenge

Publications (1)

Publication Number Publication Date
BR112022026865A2 true BR112022026865A2 (pt) 2023-01-24

Family

ID=77022283

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022026865A BR112022026865A2 (pt) 2020-06-30 2021-06-28 Pastilha

Country Status (9)

Country Link
US (1) US20230241097A1 (pt)
EP (1) EP4171739A1 (pt)
JP (1) JP2023532121A (pt)
CN (1) CN115768405A (pt)
AU (1) AU2021299267A1 (pt)
BR (1) BR112022026865A2 (pt)
CA (1) CA3187599A1 (pt)
MX (1) MX2022016202A (pt)
WO (1) WO2022005932A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485920A (en) * 1967-06-12 1969-12-23 Gen Foods Corp Analgesic compositions of aspirin and pectin
JP3087078B2 (ja) 1995-09-05 2000-09-11 安井製菓株式会社 グミとその製造方法
US6258383B1 (en) * 1998-08-14 2001-07-10 Lactoferrin Products Company Dietary supplement combining colostrum and lactoferrin in a mucosal delivery format
US20100226904A1 (en) 2009-03-05 2010-09-09 Hero Nutritionals, LLC Organic chewable supplement
DE102010011964A1 (de) * 2010-03-18 2011-09-22 Soldan Holding + Bonbonspezialitäten GmbH Süßwarenzusammensetzung mit einem Anteil an Antioxidantien

Also Published As

Publication number Publication date
MX2022016202A (es) 2023-06-07
CA3187599A1 (en) 2022-01-06
CN115768405A (zh) 2023-03-07
EP4171739A1 (en) 2023-05-03
JP2023532121A (ja) 2023-07-26
US20230241097A1 (en) 2023-08-03
WO2022005932A1 (en) 2022-01-06
AU2021299267A1 (en) 2023-02-02

Similar Documents

Publication Publication Date Title
BR112018005454A2 (pt) administração de potencializadores de cftr deuterados
NO20065453L (no) Fenoksyalkykarboksylsyrederivater i behandlingen av inflammatoriske sykdommer.
NO20090590L (no) Metabolisme modulatorer samt behandling av lidelser relatert dertil
CY1107623T1 (el) Μεθοδος αγωγης συμπτωματων ορμονικων μεταβολων, περιλαμβανομενων των εξαψεων
ECSP099178A (es) Método de tratamiento del ictus con un trombolítico
BR112023001792A2 (pt) Combinações para o tratamento de câncer
BR112022021640A2 (pt) Usos e formulações de canabinoides
BR122021012549B8 (pt) Composição de dissolução oral de melatonina com agente acidificante que torna melatonina solúvel em saliva
BR112022026865A2 (pt) Pastilha
BR112016029437A2 (pt) métodos para tratamento e prevenção de doenças de instabilidade vascular
ZA201905212B (en) Rescue treatment of post operative nausea and vomiting
BR112022018020A2 (pt) Formas cristalinas de um composto farmacêutico
BR112022006508A2 (pt) Sílica com propriedades de dissolução ultrarrápida
BR112022023044A2 (pt) Medicamento para tratamento de uma doença proliferativa, nanopartícula de ouro, e, método para fabricar nanopartículas de ouro
NO20081415L (no) Fremgangsmate for utforelse av en perkutan koronar intervensjon
BRPI0608022A2 (pt) processo para fabricação de um medicamento para tratar hipertensão, formulação anti-hipertensão e processo para fabricação de um medicamento para tratar cálculo
MD580Z (ro) Metodă miniinvazivă de instalare timpurie a implantelor dentare endoosoase în doi timpi
TR201811928A2 (tr) Soğukalginliği ve gri̇bal enfeksi̇yon tedavi̇ şurubu
BR112018072432A2 (pt) composição para os cuidados orais e método para a redução da sensibilidade e/ou remineralização dos dentes
AR128491A1 (es) Método y composición para soportar concentraciones de calcio en sangre normales en mamíferos
Arora et al. Ozone therapy in dentistry
UA101845U (ru) Способ лечения генерализованного пародонтита у больных, проживающих в экологически неблагоприятных условиях
AR034199A1 (es) Composicion farmacologica liquida para el tratamiento de enfermedades oseas y procedimientos para su elaboracion
Gisbert et al. Empirical Helicobacter pylori “rescue” therapy after failure of two eradication treatments,”
UA117043U (uk) Спосіб лікування хронічного періодонтиту